ANZCTR12623000220662

The use of a handwriting app for diagnosis of Parkinson's disease for people living in rural and remote communities. A comparative study between people with early to mid-stage Parkinson's disease and age-matched healthy volunteers.

A comparative clinical study of a handwriting app for the diagnosis of Parkinson's disease for people living in rural and remote communities. A comparative study between people with early to mid-stage Parkinson's disease and age-matched healthy volunteers.
RMIT University·Not Applicable·Australian New Zealand Clinical Trials Registry·diagnostic testNot yet recruiting
Study focus
Disease/Condition
Parkinson's disease
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
RMIT University
Location
Australia
Timeline & enrollment
Phase
Not Applicable
Start date
Nov 13, 2023
End date
Nov 20, 2026
Primary outcome

Analysis of the dynamics of sketching (drawing/tracing) using 2 parameters of measurement in combination - speed and pen pressure from the electronic drawing files of each participant.;; Analysis of the dynamics of writing text using 2 parameters of measurement in combination - speed and pen pressure from electronic handwriting files.

Summary

Parkinson’s disease is characterised by impaired motor function including stiffness, bradykinesia and tremor. These changes also affect hand writing causing changes in writing kinematics and pen pressure. Changes in hand writing may also be an early marker of Parkinson’s disease. Computerised graphic tablets are capable of analysing the dynamic aspects of writing. The aim of this study is to ascertain features of different hand writing tasks that are most useful in identifying differences in hand writing features between Parkinson’s disease patients and healthy age-matched controls using a computerised graphic tablet. The hypothesis is that Parkinson’s disease patients will exhibit significantly different dynamic features of hand writing compared with healthy age-matched controls.

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
Registry
Australian New Zealand Clinical Trials Registry
Trial ID
ANZCTR12623000220662
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for ANZCTR12623000220662 through Pure Global AI's free database. This Not Applicable trial is sponsored by RMIT University and is currently Not yet recruiting. The study focuses on Parkinson's disease.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.